Robert D. Arnold
Impact in
- Drug Discovery top 1%
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 20
-
- Veterinary Pharmacology and Anesthesia 14
- Co-authors
- Brian S. Cummings (12 shared papers)Wided Najahi‐Missaoui (2 shared papers)Ramapuram Jayachandra Babu (18 shared papers)Ishwor Poudel (16 shared papers)Nhat D. Quach (3 shared papers)Manjusha Annaji (13 shared papers)Ben Nie (12 shared papers)Amit Kumar Tiwari (10 shared papers)
- Journals
- American Journal of Veterinary Research (6 papers)International Journal of Molecular Sciences (5 papers)Scientific Reports (4 papers)AAPS PharmSciTech (4 papers)Journal of Pharmaceutical Sciences (3 papers)
- Partner nations
- United StatesSaudi ArabiaUnited Arab Emirates
In The Last Decade
Robert D. Arnold
88 papers receiving 2.9k citations
Robert D. Arnold's Hit Papers
Peers
Comparison fields: 5 of 129
- Drug Discovery 35
- Biomaterials 741
- Pharmaceutical Science 209
- Molecular Medicine 84
- Geriatrics and Gerontology 40
Countries citing papers authored by Robert D. Arnold
This map shows the geographic impact of Robert D. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Arnold more than expected).
Fields of papers citing papers by Robert D. Arnold
This network shows the impact of papers produced by Robert D. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Arnold. The network helps show where Robert D. Arnold may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert D. Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safe Nanoparticles: Are We There Yet? Hit paper breakdown → | 2020 | 458 |
| 2 | 2021 | 163 | |
| 3 | 2018 | 153 | |
| 4 | 2014 | 142 | |
| 5 | 2012 | 135 | |
| 6 | 2012 | 122 | |
| 7 | 2004 | 112 | |
| 8 | 2016 | 99 | |
| 9 | 2017 | 87 | |
| 10 | 2018 | 84 | |
| 11 | 2019 | 71 | |
| 12 | 2011 | 58 | |
| 13 | 2016 | 57 | |
| 14 | 2005 | 56 | |
| 15 | 2006 | 55 | |
| 16 | 2015 | 55 | |
| 17 | 2012 | 52 | |
| 18 | 2022 | 52 | |
| 19 | 2015 | 50 | |
| 20 | 2016 | 45 |
About Robert D. Arnold
Robert D. Arnold is a scholar working on Biomaterials, Small Animals, Cell Biology, Pharmaceutical Science and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Veterinary Pharmacology and Anesthesia (14 papers), Prostate Cancer Treatment and Research (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Orthopedic Infections and Treatments (4 papers), Nanoparticles: synthesis and applications (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Muscle metabolism and nutrition (4 papers). The work is most often cited by research in Drug Discovery (35 citations), Biomaterials (741 citations), Pharmaceutical Science (209 citations), Molecular Medicine (84 citations) and Geriatrics and Gerontology (40 citations). Robert D. Arnold has collaborated with scholars based in United States, Saudi Arabia and United Arab Emirates. Frequent co-authors include Brian S. Cummings, Wided Najahi‐Missaoui, Ramapuram Jayachandra Babu, Ishwor Poudel, Nhat D. Quach, Manjusha Annaji, Ben Nie, Amit Kumar Tiwari, Jiyoung Jung and Louise Wicker. Their work appears in journals such as American Journal of Veterinary Research, International Journal of Molecular Sciences, Scientific Reports, AAPS PharmSciTech and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.